Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma

International Journal of Oncology

Volumn 13, Issue 4, 1998, Pages 849-853

  Rio, Pascale G ^a,b   Pernin, David ^a   Bay, Jacques Olivier ^a   Albuisson, Eliane ^c   Kwiatkowski, Fabrice ^a   De Latour, Monique ^a   Bernard Gallon, Dominique J ^a   Bignon, Yves Jean ^a  

^a CENTRE JEAN PERRIN   (France)

^b INSERM   (France)

^c UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

ATM; BRCA1; BRCA2; Loss of heterozygosity; Sporadic breast cancer

Indexed keywords

ARTICLE; BREAST CARCINOGENESIS; CANCER GENETICS; CANCER GRADING; GENE LOSS; GENETIC ANALYSIS; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; ONCOGENE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

EID: 0031720208     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.13.4.849     Document Type: Article

References (31)

1. Miki Y, Swensen J, Shattuck-Eidens D, Futreal P, Harshman K, Tavtigian S, Liu Q, Cochran C, Bennett L, Ding W, Bell R, Rosenthal J, Hussey C, Tran T, MacClure M, Frye C, Hattier T, Phelps R, Haugen-Strano A, Katcher H, Yakumo K, Gholami Z, Shaffer D, Stone S, Bayer S, Wray C, Bogden R, Dayananth P, Ward J, Tonin P, Narod S, Bristow PK, Norris F, Helvering L, Morrison P, Rosteck P, Lai M, Barrett JC, Lewis C, Neuhausen S, Cannon-Albright L, Goldgar D, Wiseman R, Kamb A and Skolnick MH: A strong candidate for the breast and ovarian cancer susceptibility gene. Science 266: 66-71, 1994.
2. Wooster R, Bignell G, Lancaster J, Swift S, Seal S, Mangion J, Collins N, Gregory S, Gumbs C, Micklem G, Barfoot R, Hamoudi R, Patel S, Rice C, Biggs P, Hashim Y, Smith A, Connor F, Arason A, Gudmundsson J, Ficcnec D, Kelsell D, Ford D, Tonin P, Bishop D, Spurr N, Ponder B, Eeles R, Peto J, Devilee P, Cornelisse C, Lynch H, Narod S, Lenoir G, Egilsson V, Barkardottir R, Easton D, Bentley D, Futreal P, Ashworth A and Stratton M: Identification of the breast cancer susceptibility gene BRCA2. Nature 378: 789-792, 1995.
3. Savitsky K, Bar-Shira A, Gilad S, Rotman G, Ziv Y, Vanagaite L, Taglw DA, Smith S, Uziel T, Sfez S, Ashkenazi M, Pecker I, Frydman M, Harnik R, Patanjali SR, Simmons A, Clines GA, Sartiel A, Gatti RA, Chessa L, Sanal O, Lavin MF, Jaspers NGJ, Taylor AMR, Arlett CF, Miki T, Weissman SM, Lovett M, Collins FS and Shiloh Y: A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science 268: 1749-1753, 1995.
4. Athma P, Rappaport R and Swift M: Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet 92: 130-134, 1996.
5. Bebb G, Glickman B, Gelmon K and Gatti R: 'AT risk' for breast cancer. Lancet 349: 1784-1785, 1997.
6. Devilee P and Cornelisse C: Somatic genetic changes in human breast cancer. Biochem Biophys Acta 1198: 113-130, 1994.
7. Hamann U, Herbold C, Costa S, Solomayer E-F, Bastert G, Ulmer HU, Frenzel H and Komotowski D: Allelic imbalance on chomosome 13: evidence for the involvement of BRCA2 and RB1 in sporadic breast cancer. Cancer Res 56: 1988-1990, 1996.
8. Futreal PA, Liu Q, Shattuck-Eidens D, Cochran C, Harshman K, Tavtigian S, Bennett C, Haugen-Strano A, Swensen J, Miki Y, Eddington K, McClure M, Frye C, Weaver-Feldhaus J, Ding W, Gholami Z, Soderkvist P, Terry L, Jhanwar S, Berchuck A, Iglehart J, Marks J, Ballinger D, Barrett J, Skolnick M, Kamb A and Wiseman R: BRCA1 mutations in primary breast and ovarian carcinomas. Science 266: 120-122, 1994.
9. Merajver SD, Pham TM, Caduff RF, Chen M, Poy EL, Cooney KA, Weber BL, Collins FS, Johnston C and Frank TS: Somatic mutations in the BRCAl gene in sporadic ovarian tumours. Nat Genet 9:439-443, 1995.
10. Foster K, Harrington P, Kerr J, Russell P, Di Cioccio A, Scott I, Chenevix-Trench B, Ponder B and Gayther S: Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. Cancer Res 56: 3622-3625, 1996.
11. Lancaster J, Wooster R, Mangion J, Phelan C, Cochran C, Gumbs C, Seal S, Barfoot R, Collins N, Bignell G, Patel S, Hamoudi R, Larsson C, Wiseman R, Berchuck A, Iglehart J, Marks J, Ashworth A, Stratton M and Futreal A: BRCA2 mutations in primary breast and ovarian cancer. Nat Genet 13: 138-240, 1996.
12. Teng DH-F, Bogden R, Mitchell J, Baumgard M, Bell R, Berry S, Davis T, Ha P, Kehrer R, Jammulapati S, Chen Q, Offit K, Skolnick M, Tavtigian S, Jhanwar S, Swedlund B, Wong A and Kamb A: Low incidence of BRCA2 mutations in breast carcinoma and other cancers. Nat Genet 13: 241-244, 1996.
13. Miki Y, Katagiri T, Kasumi F, Yoshimoto T and Nakamura Y: Mutation analysis in the BRCA2 gene in primary breast cancer. Nat Genet 13: 245-247, 1996.
14. Weber BHF, Brohm M, Stec I, Backe J and Caffier H: A somatic truncating mutation in BRCA2 in a sporadic breast tumor. Am J Hum Genet 59: 962-964, 1996.
15. Dubrovic A and Simpfendorfer D: Methylation of the BRCA1 gene in sporadic breast cancer. Cancer Res 57: 3347-3350, 1997.
16. Hampton GM, Mannermaa A, Winqvist R, Alavaikko M, Blanco G, Taskinen PJ, Kiviniemi H, Newhma I, Cavenee WK and Evans GA: Loss of heterozygosity in sporadic human breast carcinoma: a common region between 11q22 and 11q23.3. Cancer Res 54: 4586-4589, 1994.
17. Carter SL, Negrini M, Baffa R, Gillum DR, Rosenberg AL, Schwartz GF and Croce CM: Loss of heterozygosity at 11q22-q23 in breast cancer. Cancer Res 54: 6270-6274, 1994.
18. Negrini M, Rasio D, Hampton GM, Sabbioni S, Rattan S, Carter SL, Rosenbcrg AL, Scharwrtz GF, Shiloh Y, Cavenee WK and Croce CM: Definition and refinement of chromosome 11 regions of LOH in breast cancer: identification of a new region at 11q23-q24. Cancer Res 55: 3003-3007, 1995.
19. Negrini M, Sabbioni S, Possati L, Rattan S, Corallini A, Barbanti-Brotano G and Croce CM: Suppression of tumorigenicity of breast cancer cells by microcell-mediated chromosome transfert: studies on chromosomes 6 and 11. Cancer Res 54: 1331-1336, 1994.
20. Man S, Ellis I, Sibbering M, Blamey R and Brook J: High level of allele loss at the FHIT and ATM genes in non-comedo ductal carcinoma in situ and grade I tubular invasive breast cancers. Cancer Res 56: 5484-5489, 1996.
21. Maniatis T, Fritsch E and Sambrook J: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, 1982.
22. Lalle P, De Latour M, Rio P and Bignon Y-J: Detection of allelic losses on 17q12-21 chromosomal region in benign lesions and malignant tumors occurring in a familial context. Oncogene 9: 437-442, 1994.
23. Couch F, Rommens J, Neuhausen S, Belanger C, Dumont M, Abel K, Bell R, Berry SRB, Cannon-Albright L, Farid L, Frye C, Hattier T, Janecki T, Jiang P, Kehrer R, Leblanc J, McArthur-Morrison J, Meney D, Miki Y, Peng Y, Samson C, Schroeder M, Snyder S, Stringfellow M, Stroup C, Swedlund B, Swensen J, Teng D, Thakur S, Tran T, Tranchant M, Welver-Feldhaus J, Wong A, Shizuya H, Labrie F, Skolnick M, Goldgar D, Kamb A, Weber B, Tavtigian S and Simard J: Generation of an integrated transcription map of the BRCA2 region on chromosome 13q12-q13. Genomics 36: 86-99, 1996.
24. Beckmann MW, Picard F, An HX and van Roeven CRC: Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. Br J Cancer 73: 1220-1226, 1996.
25. Schmutzler R, Bierhoff E, Werkhausen T, Fimmers R, Speiser P, Kubista E, Krebs D, Zeillinger R, Wiestler O and von Deimling A: Genomic deletions in the BRCA1, BRCA2 and TP53 regions associate with low expression of the estrogen receptor in sporadic breast carcinoma. Int J Cancer 74: 322-325, 1997.
26. Van den Berg J, Johannsson O, Hakansson S and Borg A: Allelic loss at chromosome 13q12-q13 is associated with poor prognosis in familial and sporadic breast cancer. Br J Cancer 74: 1615-1619, 1996.
27. Andersen T, Gaustad A, Ottestad L, Farrants G, Nesland J, Tveit K and Børresen A: Genetic alterations of the tumoursuppressor-gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer 4: 113-121, 1992.
28. Bièche I, Noguès C, Rivoilan S, Khodja A, Latil A and Lidereau R: Prognostic value of loss of heterozygosity at BRCA2 in human breast carcinoma. Br J Cancer 76: 1416-1418, 1997.
29. Vorechovsky I, Rasio D, Luo L, Monaco C, Hammarstrom L, Webster AD, Zaloudik J, Barbanti-Brodani G, James M, Russo G, Croce C and Negrini M: The ATM gene and susceptibility to breast cancer: analysis of 38 breast tumors reveals no evidence for mutation. Cancer Res 56: 2726-2732, 1996.
30. Shiloh Y: Ataxia-telangiectasia: closer to unraveling the mystery. Eur J Hum Genet 3: 116-138, 1995.
31. Kelsell D, Spurr N, Barnes D, Gusterson B and Bishop D: Combined loss of BRCA1/BRCA2 in grade 3 breast carcinoma. Lancet 347: 1554-1555, 1996.